Homeobox A10 promotes the proliferation and invasion of bladder cancer cells via regulation of matrix metalloproteinase-3

被引:10
作者
Liu, Chunlei [1 ]
Ge, Mingzhu [2 ]
Ma, Jun [1 ]
Zhang, Yanhui [1 ]
Zhao, Yanhui [1 ]
Cui, Tao [1 ]
机构
[1] Qingdao Cent Hosp, Dept Urol, 127 Si Liu Nan Rd, Qingdao 266042, Shandong, Peoples R China
[2] Qingdao Cent Hosp, Dept Ultrasound, Qingdao 266042, Shandong, Peoples R China
关键词
homeobox A10; bladder cancer; cell invasion; matrix metalloproteinase-3; HOXA10; EXPRESSION; GENE; CARCINOMA; DEREGULATION; MMP-3; RISK;
D O I
10.3892/ol.2019.10312
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Homeobox A10 (HOXA10) belongs to the family of HOX genes, which are closely connected with embryonic development and serve important roles in various tumors. However, the role of HOXA10 in bladder cancer (BC) remains unclear. In the present study, the role of HOXA10 in BC and the underlying mechanisms by which it promotes the disease progression were investigated. Immunohistochemical analysis demonstrated that the expression of the HOXA10 protein was significantly higher in BC tissues as compared with that in adjacent normal tissues. Subsequent statistical analysis revealed that upregulation of HOXA10 was significantly associated with the pathological grade and clinical stage of BC patients. In the BC cell lines T24 and 5637, silencing of HOXA10 by small interfering RNA transfection suppressed the proliferation, migration and invasion of BC cells, and led to decreased matrix metalloproteinase-3 expression. Taken together, overexpression of HOXA10 may be associated with poor prognosis in BC, and may serve as a novel antitumor therapy target for the treatment of this disease.
引用
收藏
页码:49 / 56
页数:8
相关论文
共 31 条
[1]   Incidence, survival and mortality rates of stage-specific bladder cancer in United States: A trend analysis [J].
Abdollah, Firas ;
Gandaglia, Giorgio ;
Thuret, Rodolphe ;
Schmitges, Jan ;
Tian, Zhe ;
Jeldres, Claudio ;
Passoni, Niccolo Maria ;
Briganti, Alberto ;
Shariat, Shahrokh F. ;
Perrotte, Paul ;
Montorsi, Francesco ;
Karakiewicz, Pierre I. ;
Sun, Maxine .
CANCER EPIDEMIOLOGY, 2013, 37 (03) :219-225
[2]   Trends in Bladder Cancer Incidence and Mortality: Success or Disappointment? [J].
Babjuk, Marko .
EUROPEAN UROLOGY, 2017, 71 (01) :109-+
[3]   Incidence and location of lymph node metastases in patients undergoing radical cystectomy for clinical non muscle invasive bladder cancer: Results from a prospective lymph node mapping study [J].
Bruins, Harman M. ;
Skinner, Eila C. ;
Dorin, Ryan P. ;
Ahmadi, Hamed ;
Djaladat, Hooman ;
Miranda, Gus ;
Cai, Jie ;
Daneshmand, Siamak .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (01) :24.e13-24.e19
[4]  
Carrera M, 2015, INT J CLIN EXP PATHO, V8, P3613
[5]  
Chen KN, 2005, CLIN CANCER RES, V11, P1044
[6]   Identification of aberrant promoter hypomethylation of HOXA10 in ovarian cancer [J].
Cheng, Wenjun ;
Jiang, Yi ;
Liu, Cuixia ;
Shen, Ouxi ;
Tang, Weiwei ;
Wang, Xinru .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (08) :1221-1227
[7]   HOXA10 regulates p53 expression and matrigel invasion in human breast cancer cells [J].
Chu, MC ;
Selam, FB ;
Taylor, HS .
CANCER BIOLOGY & THERAPY, 2004, 3 (06) :568-572
[8]   Incidence of fibroblast growth factor receptor 3 gene (FGFR3) A248C, S249C, G372C, and T375C mutations in bladder cancer [J].
Dodurga, Y. ;
Tataroglu, C. ;
Kesen, Z. ;
Satiroglu-Tufan, N. L. .
GENETICS AND MOLECULAR RESEARCH, 2011, 10 (01) :86-95
[9]   Methylation of the HOXA10 homeobox gene promoter is associated with endometrial cancer: A pilot study [J].
Fambrini, M. ;
Bussani, C. ;
Sorbi, F. ;
Pieralli, A. ;
Cioni, R. .
JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2013, 33 (05) :519-520
[10]   Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10+/CD44+ is potential prognostic biomarker for gastric cancer [J].
Han, Yang ;
Lu, Su ;
Wen, Yu-gang ;
Yu, Fu-dong ;
Zhu, Xing-wu ;
Qiu, Guo-qiang ;
Tang, Hua-mei ;
Peng, Zhi-hai ;
Zhou, Chong-zhi .
EUROPEAN JOURNAL OF CELL BIOLOGY, 2015, 94 (12) :642-652